Onderneming Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Aandelen
688192
CNE1000055W8
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
44,39 CNY | +3,26% | +25,40% | -7,23% |
Vakgebied
Aantal werknemers: 424
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 27-10-17 |
Wei Wen Dong
CHM | Chairman | 38 | 01-06-18 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 01-07-20 |
Qing Bei Zeng
CTO | Chief Tech/Sci/R&D Officer | 62 | 01-12-17 |
Zhen Fan Yang
CTO | Chief Tech/Sci/R&D Officer | 56 | 01-12-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 01-10-17 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 07-09-20 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 08-09-20 |
Xin Zhang
BRD | Director/Board Member | 52 | 08-09-20 |
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 27-10-17 |
Director/Board Member | 51 | 01-10-17 | |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 01-07-20 |
Bin Jiang
BRD | Director/Board Member | 60 | 08-09-20 |
Wei Wen Dong
CHM | Chairman | 38 | 01-06-18 |
Yuan Sun
BRD | Director/Board Member | 36 | 01-05-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 415 653 120 | 76 821 862 ( 18,48 %) | 0 | 18,48 % |
Bedrijfsgegevens
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Building 4 199, 245 Liangjing Road
201203, Shanghai
+
http://www.dizalpharma.comSector
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,23% | 2,55 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers 688192
- Onderneming Dizal (Jiangsu) Pharmaceutical Co., Ltd.